A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
CELZ
$2M
Mkt Cap
$0.81
-0.04%
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) has a 5-year average return on invested capital (ROIC) of -49.3%. This is below average and may indicate limited pricing power.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) has a market capitalization of $2M. It is classified as a small-cap stock.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.52%.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) operates in the Biological Products, (No Diagnostic Substances) industry, within the Healthcare sector.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) generated $-6 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) reported earnings per share (EPS) of $-2.52 in its most recent fiscal year.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. operates in the Biological Products, (No Diagnostic Substances) industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - | - |
| Net Income | -6.0M | -6.0M | -5.5M | -5.3M | -10M | 19M |
| EPS | $-2.52 | $-2.52 | $-3.71 | $-3.76 | $-72.07 | $18.70 |
| Free Cash Flow | -5.9M | -5.9M | -5.3M | -8.0M | -7.8M | 2.2M |
| ROIC | - | - | - | -52.5% | -67.7% | -27.7% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | - | - | - | 0.00 | 0.38 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | -6.1M | -6.1M | -5.7M | -5.6M | -10M | -3.1M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | 0.0% | - | - | - | -77.8% | -129.9% |
| Shares Outstanding | 2M | 2M | 1M | 1M | 0M | 1M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 0 | 0 | 0 | N/A | N/A | N/A | 165K | N/A | N/A | N/A | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | 69.2% | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | 85K | 260K | 97K | 0 | 0 | 109K | 6.3M | 2.0M | 2.4M | 2.3M | 2.3M |
| SG&A | 0 | 1K | 665K | 899K | 1.1M | 1.2M | 1.2M | 3.0M | 3.9M | 3.6M | 3.2M | 3.8M | 3.8M |
| EBIT | -19K | -21K | -760K | -1.2M | -1.1M | -1.1M | -1.1M | -3.1M | -10M | -5.6M | -5.7M | -6.1M | -6.1M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | -677.7% | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -28K | -31K | -766K | -2.7M | -14M | -8.5M | N/A | 19M | -10M | -5.3M | -5.5M | -6.0M | -6.0M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | N/M | N/A | -186.1% | N/M | -184.5% | -168.2% | N/A | -27.7% | -67.7% | -52.5% | N/A | N/A | N/A |
| ROE | 20.1% | N/A | N/A | 222.2% | 438.3% | 140.6% | N/A | -129.9% | -77.8% | N/A | N/A | N/A | 0.0% |
| ROA | -4218.7% | -121.7% | -411.7% | -1011.7% | -4014.6% | -1683.3% | N/A | 320.6% | -66.6% | -35.4% | -63.2% | -82.8% | -76.8% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -17K | -15K | -445K | -890K | -1.1M | -1.2M | -435K | 2.2M | -7.8M | -8.0M | -5.3M | -5.9M | -5.9M |
| Free Cash Flow | -17K | -15K | -455K | -890K | -1.1M | -1.2M | -435K | 2.2M | -7.8M | -8.0M | -5.3M | -5.9M | -5.9M |
| Owner Earnings | -17K | -15K | -457K | -1.0M | -1.1M | -1.2M | -672K | 1.5M | -8.0M | -8.1M | -5.4M | -6.0M | -6.0M |
| CapEx | 0 | 0 | 10K | 0 | 5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 0 | 9K | 16K | 21K | 27K | 67K | 92K | 92K | 56K | 56K | 123K | 123K |
| Growth CapEx | N/A | N/A | 0 | N/A | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 0 | 0 | 9K | 16K | 21K | 27K | 67K | 92K | 92K | 56K | 56K | 123K | 123K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 271K | 175K | 10K | 10K |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 4.1% | 5.1% | 0.0% | 0.5% |
| Stock-Based Comp | N/A | N/A | 3K | 144K | 2K | 0 | 170K | 595K | 69K | 37K | 37K | 3K | 3K |
| Debt Repayment | 0 | 0 | 0 | 0 | 405K | 263K | 0 | 443K | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | 52K | 0 | -222K | 731K | 1.9M | 2.6M | 1.5M | -6.8M | -8.3M | N/A | N/A | N/A | -7.2M |
| Cash & Equiv. | 0 | 0 | 222K | 14K | 304K | 89K | 98K | 11M | 8.3M | 3.5M | 5.9M | 7.2M | 7.2M |
| Long-Term Debt | 53K | 0 | 0 | 493K | 1.5M | 1.6M | 829K | 3.9M | 0 | N/A | N/A | N/A | N/A |
| Debt/Equity | -0.35 | N/A | 0.00 | -0.33 | -0.54 | -0.33 | -0.04 | 0.38 | 0.00 | N/A | N/A | N/A | 0.00 |
| Interest Coverage | -2.3 | -2.1 | -118.7 | -3.1 | -0.8 | -0.6 | -0.9 | -0.7 | N/A | N/A | N/A | N/A | N/A |
| Equity | -153K | N/A | -158K | -2.2M | -4.0M | -8.1M | -40M | 10M | 16M | N/A | N/A | N/A | 0 |
| Total Assets | 0 | 50K | 323K | 203K | 477K | 531K | 718K | 11M | 19M | 11M | 6.7M | 7.8M | 7.8M |
| Total Liabilities | 154K | N/A | 480K | 2.4M | 4.5M | 8.6M | 41M | 1.1M | 3.3M | N/A | N/A | N/A | N/A |
| Intangibles | N/A | 0 | 101K | 185K | 164K | 437K | 620K | 528K | 436K | 441K | 531K | 407K | 407K |
| Retained Earnings | -325K | 0 | -767K | -3.4M | -17M | -26M | -62M | -44M | -54M | -59M | -65M | -71M | -71M |
| Working Capital | -153K | 50K | -232K | -2.4M | -4.2M | -8.5M | -40M | 9.7M | 15M | 9.9M | 5.8M | 7.1M | 7.1M |
| Current Assets | 0 | 50K | 222K | 18K | 314K | 94K | 98K | 11M | 19M | 10M | 6.1M | 7.4M | 7.4M |
| Current Liabilities | 154K | 0 | 454K | 2.4M | 4.5M | 8.6M | 41M | 1.1M | 3.3M | 371K | 328K | 285K | 285K |
| Per Share Data | |||||||||||||
| EPS | -0.00 | -0.00 | -0.03 | -0.09 | -59.79 | -6.44 | -104.48 | 18.70 | -72.07 | -3.76 | -3.71 | -2.52 | -2.52 |
| Owner EPS | -0.00 | -0.00 | -0.02 | -0.03 | -4.71 | -0.94 | -0.73 | 1.49 | -56.53 | -5.78 | -3.64 | -2.52 | -2.52 |
| Book Value | -0.00 | N/A | -0.01 | -0.07 | -17.49 | -6.13 | -43.16 | 9.95 | 112.71 | N/A | N/A | N/A | 0.00 |
| Cash Flow/Share | -0.00 | -0.00 | -0.02 | -0.03 | -4.61 | -0.92 | -0.47 | 2.16 | -55.39 | -5.71 | -3.58 | -2.46 | -2.47 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 38.2M | 67.5M | 26.9M | 31.1M | 0.2M | 1.3M | 0.9M | 1.0M | 0.1M | 1.4M | 1.5M | 2.4M | 2.4M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.4 | N/A | N/A | N/A | N/A | -0.3 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 9.6 | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.9 | 0.3 | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | 214.7 | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | -7.3% | -1.2% | -8.7% | -1.6% | -2.4% | -3.4% | 7.6% | -157.5% | -122.8% | -155.0% | N/A | -303.8% |
| Market Cap | N/A | 199K | 39M | 10M | 66M | 51M | 13M | 29M | 5.0M | 6.5M | 3.4M | 0 | 1.9M |
| Avg. Price | N/A | 8,250.00 | 234,198.62 | 250,001.09 | 14,514.88 | 3,713.99 | 54.21 | 140.15 | 12.44 | 5.27 | 3.90 | 0.00 | 0.81 |
| Year-End Price | N/A | 8,250.00 | 382,500.00 | 8,625.00 | 5,550.00 | 225.00 | 19.50 | 20.80 | 3.65 | 4.65 | 2.31 | 0.00 | 0.81 |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. passes 1 of 9 quality checks, indicating weak fundamentals.
Total shareholder yield (buybacks) is 0.5%. At current prices, the estimated annualized return to fair value is -25.7%.
The Ledger Terminal provides 16 years of financial data for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.